4.5 Article

Caspase-3 activation in oligodendrocytes from the myelin-deficient rat

Journal

JOURNAL OF NEUROSCIENCE RESEARCH
Volume 64, Issue 4, Pages 371-379

Publisher

WILEY-LISS
DOI: 10.1002/jnr.1088

Keywords

myelin-deficient rat; proteolipid protein; oligodendrocytes; apoptosis; caspases

Categories

Funding

  1. NINDS NIH HHS [T32-NS07413, NS34017] Funding Source: Medline

Ask authors/readers for more resources

The myelin-deficient (MD) rat has a point mutation in its proteolipid protein (PLP) gene that causes severe dysmyelination and oligodendrocyte cell death. Using an in vitro model, we have shown that MD oligodendrocytes initially differentiate similarly to wild-type cells, expressing galactocerebroside, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin basic protein. However, at the time when PLP expression would normally begin, the MD oligodendrocytes die via an apoptotic pathway involving caspase activation. The active form of caspase-3 was detected, along with the cleavage products of poly-(ADP-ribose) polymerase (PARP) and spectrin, major targets of caspase-mediated proteolysis. A specific inhibitor of casapse-3, Ac-DEVD-CMK, reduced apoptosis in MD oligodendrocytes, but the rescued cells did not mature fully or express myelin-oligodendrocyte glycoprotein. These results suggest that mutant PLP affects not only cell death but also oligodendrocyte differentiation. (C) 2001 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available